Bio-Techne Advances Spatial Biology with Modular Expansion of COMET(TM) Suite
MWN-AI** Summary
Bio-Techne Corporation (NASDAQ: TECH) has recently announced a significant enhancement to its COMET™ spatial biology suite with the introduction of SPYRE™ Focus Panels and SPYRE™ Amplification Kits. These new additions aim to provide researchers with greater flexibility and sensitivity in analyzing complex tissue samples, facilitating deeper insights into biological phenomena.
The SPYRE™ Focus Panels, including specialized panels for stroma and vessel analysis, enable modular assembly of antibody panels. This aids in the development of multiplex assays while reducing the time required for optimization. Leveraging validated antibodies and ready-to-use protocols, these panels streamline experimental setup and allow for integration with a laboratory's existing antibody library.
Moreover, the SPYRE™ Amplification Kits utilize sequential and enhanced layered amplification (seqLA™) technology to significantly improve the detection of low-abundance and hard-to-detect targets, ensuring that researchers can capture all relevant biological information.
To complement these advancements, Bio-Techne has upgraded its HORIZON™ Image Analysis Software, optimized for the hyperplex images generated within the COMET suite using the new SPYRE tools. This enhancement aims to streamline tissue analysis further, allowing for more accurate interpretation of experimental results.
Steve Crouse, President of Bio-Techne's Diagnostics and Spatial Biology Segment, emphasized that these innovations underscore Bio-Techne's commitment to providing cutting-edge tools that simplify the research process, ultimately enabling researchers to derive meaningful insights with confidence.
The introduction of SPYRE technologies represents a crucial step in Bio-Techne's ongoing mission to enhance research capabilities in spatial biology, providing scientists with the tools necessary for investigating complex biological interactions within tissues. This modular expansion reaffirms Bio-Techne’s position as a leader in life sciences, as evidenced by its robust sales performance and extensive product portfolio.
MWN-AI** Analysis
Bio-Techne Corporation (NASDAQ: TECH) has recently expanded its COMET™ Suite to include SPYRE™ Focus Panels and Amplification Kits, significantly enhancing its capabilities in spatial biology. This modular expansion not only boosts the flexibility and sensitivity of their products but also aligns with the increasing market demand for advanced research tools in the life sciences sector.
The new SPYRE Focus Panels, which incorporate modules aimed at stroma and vessel interrogation, offer researchers the opportunity to conduct more targeted analyses with reduced optimization times. The SPYRE Amplification Kits utilize seqLA™ technology to improve the detection of elusive low-abundance targets, further catering to complex tissue sample analysis. This innovation could greatly enhance research efficiency and data quality, which are critical in fields like cancer research and personalized medicine.
From an investment perspective, Bio-Techne's strategic developments position it favorably within a growing market. The global spatial biology market is expected to see substantial growth fueled by the increasing demand for precision medicine and targeted therapies. With Bio-Techne generating over $1.2 billion in net sales for fiscal 2025, its robust financial standing, combined with innovative product offerings, suggests a positive outlook.
Investors should closely monitor Bio-Techne’s market performance as these new products are integrated into research workflows. The commitment to innovation showcases the company’s drive to enhance researcher capabilities, which in turn can lead to increased product adoption and sales growth. As researchers continually seek efficient and effective tools for data generation, Bio-Techne's advancements could solidify its competitive advantage and potentially drive share price growth in the long term.
In summary, Bio-Techne’s recent innovations in spatial biology present a compelling opportunity for investors looking to capitalize on advancements in life science tools, making it a stock worth considering for a diversified portfolio.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
- New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows.
- SPYRE™ Amplification Kits leverage sequential and enhanced layered amplification (seqLA™) technology enabling improved detection of low-abundance and challenging targets.
- Enhancements strengthen the fully integrated COMET spatial biology ecosystem, supporting increased consumables adoption and panel expansion.
MINNEAPOLIS, March 25, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the expansion of its COMET™ solution portfolio with the addition of the new SPYRE™ Focus Panels and SPYRE™ Amplification Kits. Together, these strengthen the COMET technology modular, automated spatial biology workflow, delivering expanded flexibility, greater sensitivity, and enabling deeper, more focused interrogation of biologically meaningful data from initial assay design through final interpretation. To support these updates, new features of HORIZON™ Image Analysis Software have also been introduced, tailored for COMET hyperplex images using the new SPYRE tools, further streamlining tissue analysis.
"Researchers need tools that make it easier to extract meaningful answers from complex tissue samples," said Steve Crouse, President of Bio-Techne's Diagnostics and Spatial Biology Segment. "Innovation is one of Bio-Techne's key differentiators, and SPYRE Focus Panels and SPYRE Amplification Kits reflect that strength. By incorporating these capabilities into the COMET Suite, we are giving researchers a more flexible, faster, and higher sensitivity workflow that enables researchers to achieve deeper insights with greater confidence."
SPYRE™ Antibody Panels, including the newly introduced Stroma and Vessel Focused Panels, are modular antibody panels designed to enable flexible multiplex assay design while reducing optimization time. Panels leverage validated antibodies with ready-to-use protocols to streamline setup while maintaining flexibility to incorporate markers from a lab's own antibody library. SPYRE™ Amplification Kits use seqLA™ technology to improve the detection of low?abundance and difficult?to?detect targets.
"Utilizing the pre-optimized SPYRE panel has not only increased the capacity of conventional multiplex immunofluorescence but also enabled a one-day experimental protocol," said Prof. Joanne Edwards, Professor of Translational Cancer Pathology, University of Glasgow. "The COMET workflow is straightforward and flexible, allowing us to easily integrate our own antibodies of interest. This technology provides insightful data, facilitating the simultaneous investigation of tumor and microenvironment cells within the same sample."
Together, SPYRE Focus Panels and SPYRE Amplification Kits strengthen Bio-Techne's commitment to deliver a fully integrated, modular, and automated spatial biology ecosystem that accelerates research and preclinical therapeutic development. These innovations continue to empower researchers to generate richer data and deeper biological understanding from every tissue sample.
ABOUT BIO-TECHNE:
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for?the research?and clinical diagnostic communities. Bio-Techne products?assist?scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for?accurate?clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over?$1.2 billion?in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information, visit?www.bio-techne.com?or follow the Company on social media at?LinkedIn,?X?and?YouTube.
MEDIA CONTACTS:
Corporate Communications
media.relations@bio-techne.com
David Clair, Vice President Investor Relations
ir@bio-techne.com
SOURCE Bio-Techne Corporation
FAQ**
How does the expansion of the COMET Suite with SPYRE Focus Panels and Amplification Kits enhance data acquisition for researchers using Bio-Techne Corp TECH's spatial biology tools?
In what ways do the newly introduced SPYRE™ Focus Panels support more efficient multiplex assay design within the Bio-Techne Corp TECH ecosystem?
Can you elaborate on the seqLA™ technology utilized in the SPYRE Amplification Kits and how it improves detection capabilities for low-abundance targets in Bio-Techne Corp TECH’s offerings?
How does Bio-Techne Corp TECH plan to leverage the advancements in the HORIZON™ Image Analysis Software to streamline tissue analysis for its customers?
**MWN-AI FAQ is based on asking OpenAI questions about Bio-Techne Corp (NASDAQ: TECH).
NASDAQ: TECH
TECH Trading
0.46% G/L:
$53.48 Last:
1,280,769 Volume:
$52.90 Open:
